Theraclion SA (ALTHE.PA)
EUR 0.36
(-2.72%)
EUR 0.36
(-2.72%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -4.48 Million EUR | 61.21% |
| 2022 | -5.74 Million EUR | -39.95% |
| 2021 | -5.32 Million EUR | -6.13% |
| 2020 | -4.14 Million EUR | 7.37% |
| 2019 | -4.47 Million EUR | 32.37% |
| 2018 | -6.62 Million EUR | 1.66% |
| 2017 | -6.73 Million EUR | 6.05% |
| 2016 | -7.16 Million EUR | -4.43% |
| 2015 | -6.72 Million EUR | -47.47% |
| 2014 | -4.66 Million EUR | -9.66% |
| 2013 | -4.06 Million EUR | -32.36% |
| 2012 | -3.2 Million EUR | -84.99% |
| 2011 | -1.72 Million EUR | 12.34% |
| 2010 | -1.97 Million EUR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -2.86 Million EUR | 0.0% |
| 2023 Q2 | -3.07 Million EUR | 0.0% |
| 2023 Q4 | 66.39 Thousand EUR | 0.0% |
| 2023 FY | - EUR | 61.21% |
| 2022 Q2 | -3.36 Million EUR | 0.0% |
| 2022 FY | - EUR | -39.95% |
| 2022 Q4 | -2.78 Million EUR | 0.0% |
| 2021 FY | - EUR | -6.13% |
| 2021 Q2 | -1.88 Million EUR | 0.0% |
| 2021 Q4 | -4.4 Million EUR | 0.0% |
| 2020 Q2 | -1.99 Million EUR | 0.0% |
| 2020 Q4 | -2.06 Million EUR | 0.0% |
| 2020 FY | - EUR | 7.37% |
| 2019 Q2 | -2.04 Million EUR | 0.0% |
| 2019 Q4 | -2.43 Million EUR | 0.0% |
| 2019 FY | - EUR | 32.37% |
| 2018 Q4 | -2.62 Million EUR | 0.0% |
| 2018 Q2 | -4 Million EUR | 0.0% |
| 2018 FY | - EUR | 1.66% |
| 2017 Q2 | -3.75 Million EUR | 0.0% |
| 2017 Q4 | -2.97 Million EUR | 0.0% |
| 2017 FY | - EUR | 6.05% |
| 2016 Q4 | -3.51 Million EUR | 0.0% |
| 2016 FY | - EUR | -4.43% |
| 2016 Q2 | -3.65 Million EUR | 0.0% |
| 2015 Q2 | -3.2 Million EUR | 0.0% |
| 2015 Q4 | -3.65 Million EUR | 0.0% |
| 2015 FY | - EUR | -47.47% |
| 2014 FY | - EUR | -9.66% |
| 2014 Q4 | -2.4 Million EUR | 0.0% |
| 2014 Q2 | -2.24 Million EUR | 0.0% |
| 2013 Q3 | -1.04 Million EUR | 52.36% |
| 2013 Q4 | -2.04 Million EUR | -95.68% |
| 2013 FY | - EUR | -32.36% |
| 2013 Q2 | -2.19 Million EUR | 0.0% |
| 2012 FY | - EUR | -84.99% |
| 2012 Q4 | -1.04 Million EUR | -29.39% |
| 2012 Q1 | -809.05 Thousand EUR | 0.0% |
| 2012 Q2 | -809.05 Thousand EUR | 0.0% |
| 2012 Q3 | -809.05 Thousand EUR | 0.0% |
| 2011 Q3 | -432.76 Thousand EUR | 0.0% |
| 2011 FY | - EUR | 12.34% |
| 2011 Q1 | -432.76 Thousand EUR | 0.0% |
| 2011 Q2 | -432.76 Thousand EUR | 0.0% |
| 2011 Q4 | -809.05 Thousand EUR | -86.95% |
| 2010 Q3 | -501.02 Thousand EUR | 0.0% |
| 2010 Q2 | -501.02 Thousand EUR | 0.0% |
| 2010 Q1 | -501.02 Thousand EUR | 0.0% |
| 2010 FY | - EUR | 0.0% |
| 2010 Q4 | -432.76 Thousand EUR | 13.62% |
| 2009 Q4 | -501.02 Thousand EUR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Affluent Medical SA | -13.34 Million EUR | 66.37% |
| Bluelinea Société Anonyme | -323.98 EUR | -1384936.113% |
| Carmat SA | -50.45 Million EUR | 91.106% |
| Diagnostic Medical Systems S.A. | -7.05 Million EUR | 36.414% |
| Euromedis Groupe | -4.43 Million EUR | -1.174% |
| Eurobio Scientific Société anonyme | 18.98 Million EUR | 123.634% |
| Ikonisys S.A. | -2.34 Million EUR | -91.148% |
| Implanet S.A. | -5.07 Million EUR | 11.616% |
| Median Technologies SA | -19.58 Million EUR | 77.088% |
| SpineGuard SA | -3.49 Million EUR | -28.323% |
| Euroapi S.A. | -155.39 Million EUR | 97.112% |
| Guerbet SA | 98.83 Million EUR | 104.54% |
| Ion Beam Applications SA | 12.53 Million EUR | 135.812% |
| Koninklijke Philips N.V. | 1.04 Billion EUR | 100.431% |
| Sequana Medical NV | -29.13 Million EUR | 84.599% |